β-blocker

ဢိင်းၵလဵတ်ႈ

ႁိၵ်ႈ

β-blocker (တူဝ်ၼမ် β-blockers)

1. တူဝ်ယေႃႈ ၶွင် beta blocker။
   • 2008 ၾႅပ်ႇဝႃႇရီႇ 28, ironjustice, “Beta-Blocker”, in sci.med.cardiology, Usenet^[1], retrieved 2022-05-17:

     Carvedilol, an antihypertensive agent, has been in clinical use for several years. In addition to its function as a β-blocker, carvedilol has been shown to act as an antioxidant.

   • 2008, C.J. van Boxtel, B. Santoso, I.R. Edwards, Drug Benefits and Risks: International Textbook of Clinical Pharmacology - Revised 2nd Edition‎^[2], page 325:

     Blockade of β₂-adrenoceptors by non-selective β-blockers causes side-effects such as bronchoconstriction, vasoconstriction and hypoglycaemia.

   • 2016, Anne H. Child, Diagnosis and Management of Marfan Syndrome‎^[3], page 51:

     β-blocker inhibits adrenaline β activation release into blood from sympathetic nerves and adrenal gland. In the heart, β-receptor stimulation increases heart rate and cardiac contraction, and excitation conduction in atrioventricular node. Thus β-blocker therapy decreases heart rate, cardiac contraction and myocardial oxygen consumption.